Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Diamond Lake Minerals Inc. (DLMI) Welcomes Brian J. Esposito As Company CEO In Addition To Seven New Strategic Advisors

Diamond Lake Minerals (OTC: DLMI), a company positioning itself as a rapidly developing leader in the digital asset and security token space, recently announced the appointment of a new CEO and several advisors, alongside its strategic rebranding. The addition of Brian J. Esposito as new CEO, plus board members Agnes Budzyn, Anthony Scaramucci, Larry Namer, […]

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) Eyes Growth on New Pricing for SekurVPN Packages, Launch of Communication Suite in German Language

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0), a global leader in Swiss-hosted secure data management and communication solutions, has consistently endeavored to prioritize requests from its existing and would-be customers, launching products and solutions that cater to customers’ professed needs. Earlier this year, the company launched SekurVPN, the world’s first non-big-tech-powered, Swiss-hosted privacy-focused […]

Mountain Top Properties Inc. (MTPP) Is ‘One to Watch’

Mountain Top Properties (OTC: MTPP) is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment. Mountain Top Properties was incorporated in 1990 and is based in Liverpool, New York, with offices […]

SenesTech Inc. (NASDAQ: SNES) Geometrically Increases its Addressable Market with the Addition of Evolve(TM) Soft Bait to its Portfolio

SenesTech (NASDAQ: SNES), a rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats, just announced the launch of its Evolve(TM) Soft Bait (“Evolve”), a minimum-risk solution in a new form, designed to reduce fertility in rats. As a potential solution to the root cause of pest problems […]

Clene Inc. (NASDAQ: CLNN) Reports Improved Survival Status in ALS Patients Treated with CNM-Au8(R) on Follow-Up Analysis; Announces Peer-Reviewed Study

Amyotrophic lateral sclerosis (“ALS”), or Lou Gehrig’s disease, is a progressive and degenerative neuromuscular disease that destroys nerve cells known as motor neurons, which control voluntary muscle movement (https://ibn.fm/bgJGu). A fatal neurological disorder, ALS lowers the life expectancy of patients to two to five years post-diagnosis, although some patients may live longer, as was the […]

Longeveron Inc. (NASDAQ: LGVN) Validates Safety and Therapeutic Potential of its Lomecel-B(TM) Lead Investigational Product in its CLEAR MIND Phase 2a Clinical Trial

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions, just announced positive top-line results from its CLEAR MIND Phase 2a clinical trial for treating mild Alzheimer’s disease. Most notably, the primary endpoint of safety was met based on statistical and medical assessment, with only one Serious Adverse Event (“SAE”) […]

PaxMedica Inc.’s (NASDAQ: PXMD) CEO and Corporate Communications Chief Discuss Regulatory Strategy for Lead Drug Candidate and Future Plans in Recent Bell2Bell Podcast Interview

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company specializing in innovative treatments for unmet needs in neurodevelopmental disorders, has recently introduced a groundbreaking regulatory strategy that could potentially pave the way for the approval of its lead product candidate, Suramin, in the United States. During a recent episode of the Bell2Bell (“B2B”) Podcast, Chairman and CEO […]

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Showcase Its Boutique End-to-End CDMO Services at the Premier CPHI Barcelona Event

Scinai Immunotherapeutics (NASDAQ: SCNI), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, will be showcasing its Contract Development and Manufacturing Organization (“CDMO”) services at CPHI Barcelona, a premier three-day event that brings together pharmaceutical professionals, industry leaders, and businesses to advance human health. The event is scheduled for October 24 to […]

DGE 4th Next Generation MSL Excellence Summit 2023: Navigating Thought Leader Engagement in the Digital Age

DGE’S 4th Next Generation MSL Excellence Summit will be held on November 13-14, 2023 in Philadelphia, along with a live streaming option. The event revolves around offering lucrative thought leader engagement strategies to MSLs and field executives along with data, tools, and tips to engage with their audiences. As remote meetings have become the preferred […]

 

From Our Blog

SS Innovations International, Inc. (NASDAQ: SSII) CEO Outlines Growth Strategy as SSi Mantra Expands Robotic Surgery, Telesurgery, and Global Reach

November 6, 2026

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is seeing increased adoption of its SSi Mantra surgical robotic platform, with CEO Dr. Sudhir Srivastava telling The Motley Fool’s interviewer Rachel Warren that the company’s commercial growth reflects a combination of technological capabilities, clinical experience and affordability (https://ibn.fm/EJk05). During the interview, Srivastava […]

Rotate your device 90° to view site.